Bottom line
BBH vs HTEC: the short answer
BBH (VanEck Biotech ETF) and HTEC (ROBO Global(R) Healthcare Technology and Innovation ETF) are quite different portfolios: only about 24% of their top holdings (by weight) are shared.
But HTEC is far broader, holding 63 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
BBH is cheaper at 0.35% vs 0.68% — a difference of $33 a year per $10,000 invested.
Over five years, BBH returned +2.7% a year vs −3.9% for HTEC.
Updated Nov 19, 2026
BBH vs HTEC side by side
| BBH | HTEC | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | VanEck | Innovator |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.35% | 0.68% |
| Annual cost per $10k | $35 | $68 |
| 10-yr cost on $10k (prospectus) | $443 | $979 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +21.2% | +24.0% |
| 5-yr return (annualized) | +2.7% | −3.9% |
| 10-yr return (annualized) | +4.5% | — |
| Best quarter | +27.6% | +30.7% |
| Worst quarter | −18.2% | −20.8% |
| Net assets (fund) | $395.6M | $69.1M |
| Number of holdings | 25 | 63 |
| Portfolio turnover | 19% | 38% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BBH | HTEC | Difference |
|---|---|---|---|
| 2025 | +21.2% | +24.0% | −2.8% |
| 2024 | −4.4% | +2.8% | −7.2% |
| 2023 | +3.9% | −3.0% | +6.9% |
| 2022 | −15.1% | −33.6% | +18.5% |
| 2021 | +11.8% | −0.2% | +12.0% |
| 2020 | +22.1% | +65.2% | −43.2% |
Source: Fund prospectus bar charts
Holdings overlap
7 of BBH's top 25 holdings also appear in HTEC's top 25.
| Holding | BBH | HTEC |
|---|---|---|
| Vertex Pharmaceuticals Inc | 9.10% | 1.91% |
| Regeneron Pharmaceuticals Inc | 6.21% | 1.97% |
| Natera Inc | 4.92% | 2.23% |
| IQVIA Holdings Inc | 4.31% | 2.10% |
| Illumina Inc | 3.17% | 2.09% |
| Incyte Corp | 2.49% | 1.80% |
| Charles River Laboratories International Inc | 1.50% | 1.71% |
Source: SEC Form N-PORT
BBH top 10
- Amgen Inc — 15.25%
- Gilead Sciences Inc — 12.79%
- Vertex Pharmaceuticals Inc — 9.10%
- Regeneron Pharmaceuticals Inc — 6.21%
- Revolution Medicines Inc — 5.27%
- Argenx SE — 4.97%
- Natera Inc — 4.92%
- IQVIA Holdings Inc — 4.31%
- Alnylam Pharmaceuticals Inc — 3.83%
- Biogen Inc — 3.63%
HTEC top 10
- Caredx, Inc. — 2.68%
- Guardant Health, Inc. — 2.31%
- Natera, Inc. — 2.23%
- Twist Bioscience Corp — 2.23%
- Thermo Fisher Scientific Incorporated — 2.18%
- Medpace Holdings, Inc. — 2.12%
- Adaptive Biotechnologies Corporation — 2.11%
- Iqvia Holdings Inc — 2.10%
- Illumina, Inc. — 2.09%
- Arrowhead Pharmaceuticals, Inc. — 2.08%
FAQ
What is the difference between BBH and HTEC?
Which is cheaper, BBH or HTEC?
Should I own both BBH and HTEC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.